HAZCpaC

Status
Phase 2
Condition
COVID-19
Intervention Type
Oral Drug
Funder Type
Organization | University

Drug Details

Quintuple therapy with drugs Hydroxychloroquine and Azithromycin, and dietary supplements Vitamin C, Vitamin D & Zinc.

Study Purpose

This is a Phase II interventional study will test the efficacy of quintuple therapy (Hydroxychloroquine, Azithromycin, Vitamin C, Vitamin D, and Zinc) in the treatment of patients with COVID-19 infection. In this study patients will be treated with a combination therapy to determine if this combination can effectively treat COVID-19. The study will last 24 weeks.

Find a Clinical Trial

 

footer_txt_bblBook a PFF Ambassador for your event.   Call 844.TalkPFF >